Evidence supporting the use of: Soybean
For the health condition: Estrogen (low)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Soybean is used to support or treat low estrogen levels primarily due to its content of isoflavones, which are a class of phytoestrogens—plant-derived compounds with structural similarity to human estrogen. Isoflavones, such as genistein and daidzein, can bind to estrogen receptors in the body and exert mild estrogenic or anti-estrogenic effects, depending on the hormonal environment. Scientific studies, particularly in postmenopausal women, have investigated the potential of soy isoflavones to alleviate symptoms related to low estrogen, such as hot flashes, bone density loss, and cardiovascular risk.

While some randomized controlled trials and meta-analyses suggest modest benefits of soy isoflavones in reducing menopausal symptoms and improving markers of bone health, the results are inconsistent. The estrogenic activity of soy isoflavones is much weaker than endogenous estrogen, and their effectiveness can vary based on individual factors such as gut microbiota composition (which affects isoflavone metabolism) and genetic background. Nevertheless, soy foods are widely used and recommended in some guidelines as a non-hormonal option for symptom management in menopause. Safety concerns are generally minimal for dietary soy intake; however, isoflavone supplements should be used with caution, especially in individuals with a history of hormone-sensitive cancers.

In summary, there is scientific evidence supporting the use of soybean isoflavones for mild estrogenic support, but the strength and consistency of the evidence are moderate. Soybean is not a replacement for estrogen therapy but may offer some benefit for those seeking non-hormonal options.

More about soybean
More about Estrogen (low)